Opendata, web and dolomites

Brevel

A solar based, internally-illuminated bioreactor for microalgae cultivation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Brevel" data sheet

The following table provides information about the project.

Coordinator
BREVEL 

Organization address
address: HAZAIT 12
city: REHOVOT
postcode: 7634912
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.brevel.co.il
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BREVEL IL (REHOVOT) coordinator 50˙000.00

Map

 Project objective

Microalgae can be of great benefit as a food source, as a natural source for a wide range of products and as biomass for production of biofuels as they can replace synthetic and/or fossil biomass, but they are far from reaching their commercial potential, because their cultivation is expensive and inefficient, limiting their use to high-value markets. An important product derived from microalgae is naturally produced Astaxanthin that can replace the current synthetically produced Astaxanthin used in salmon feed. For health reasons, consumers and regulators have started demanding replacing synthetic sources of Astaxanthin by natural sources. Brevel has created a novel microalgae cultivation system based on an internally illuminated photo bioreactor. Our system allows for microalgae production to become affordable and enables the stable cultivation of microalgae at a high capacity and resource efficient method. The unique approach lies in the internal volumetric illumination by concentrating and transporting sunlight by optical fibers. Brevel Ltd. was founded by three brothers in 2016 whose background is in microalgae production, physics and healthcare. The company is owned by the founders who invested €350,000 of their own savings as seed funding. Whilst the total market size for microalgae is almost €3 billion, we will first target the Astaxanthin market that had a €600 million size in 2016. Over 90% of this is manufactured synthetically due to the lower production cost. We would be the first to be able to compete with the synthetic alternative with natural Astaxanthin, which would greatly profit EU consumers who have access to eat healthier salmon. With the Phase 1 project, we want to study the feasibility of creating a small-scale and then large-scale production plant (with 5 and 50 production systems respectively). Once we succeed, our initial product will be Astaxanthin sold to salmon feed manufacturers at a price comparable to the current synthetic one.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BREVEL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BREVEL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More